People

Chris Swain

parkinsons.org.uk

Chris Swain is a published External Drug Discovery Adviser with the Parkinson’s Research Ventures programme. Own biography: Chris founded Cambridge MedChem Consulting in May 2006, where he remains Director. Prior to that he spent 20 years at Merck where he was a Senior Director responsible for a medicinal chemistry and the computational chemistry research group, He was the Chemistry Director of the project team that discovered and developed the NK1 antagonist Emend. His current activities include, providing medicinal chemistry and computational chemistry support to small and mid-cap sized Pharma companies, academic groups and start-ups. Several of these projects have resulted in molecules undergoing clinical studies. Chris has over 100 peer reviewed publications. The adviser/operating affiliation is distinct from a statutory directorship or personal cash check.